Anebulo Pharmaceuticals
ANEB
ANEB
12 hedge funds and large institutions have $17.1M invested in Anebulo Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
$17.7K |
2 |
Wells Fargo
San Francisco,
California
|
$131 |
Top Sellers
1 |
TRCT
Tower Research Capital (TRC)
New York
|
$9K |
2 |
UBS Group
Zurich,
Switzerland
|
$4.1K |
3 |
LA
LVW Advisors
Pittsford,
New York
|
$1.63M |
4 |
Morgan Stanley
New York
|
$0 |